glutathione and triple negative breast cancer CD36 enhances sensitivity of cells to palmitate-induced ferroptosis Glutathione depletion and dihydroorotate dehydrogenase
Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Glutathione Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor Positive Triple Negative Breast Cancer ACS Nano
Pay in 4 interest-free payments of $5.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15



